Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-03

Clinical Trial Update: Acute Olanzapine and Lipid Response [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on acute olanzapine and lipid response in healthy participants spanning Phase 2 and Phase 3. The status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Healthy | Phase 2, Phase 3 | Status: UNKNOWN